cdc2 gene expression is under the control of multiple factors. Although E2F/DP proteins have been reported to play a central role, they cannot account for all aspects of the ®ne modulation of cdc2 gene expression during cell cycle and embryonic development. To characterize the transcription factors that control cdc2 gene expression during nerve cell dierentiation in avians, we have previously cloned the quail cdc2 gene promoter region. We had identi®ed an octamer (CAGGTGGC) containing an E-box, which has important activity in regulating cdc2 transcription. Using in vivo genomic footprinting experiments, we show here that this motif, currently named IG, is the target of binding proteins at dierent stages of neuroretina development, con®rming its importance as a regulatory response element for cdc2 gene expression. A subset of Helix ± Loop ± Helix family of transcription factors, known as Upstream Stimulatory Factors (USFs) speci®cally bind to this sequence as dimers. Moreover, our results indicate that USFs transactivate the promoter of cdc2 via the IG motif. These data may help to better understand the mechanisms that control cell division in dierentiating nerve cells.
Introduction p34
cdc2 (cdk1), the ®rst cyclin dependent kinase, plays a central role as a mitotic regulator at the G2/M transition in eukaryotic cells (Nurse, 1993; DoreÂ e and Galas, 1994) . In higher eukaryotes, the control of cdc2 gene expression has been shown to play a central role during both cell cycle and cell dierentiation (Coleman and Dunphy, 1994) . Deregulation of cdc2 expression has generally serious consequences, and can lead to cell death (Fotedar et al., 1995; Shimizu et al., 1995b) . Understanding the mechanisms monitoring the expression of this gene is therefore of fundamental importance.
Among the various transcription factors regulating cdc2 gene expression, E2F/DP complexes have probably been the most thoroughly studied. It is generally accepted that cdc2 transcription is switched o in G1, due in part to the inhibition of E2F activity by the members of the Retinoblastoma (Rb) family: p105
Rb , p107 and p130 (Cobrinik, 1996; Sardet et al., 1997) . At the beginning of S phase, inactivation of Rb family members by phosphorylation allows the activation of cdc2 transcription by E2F/DP. Expression of cdc2 is then down-regulated in G2/M until the following G1/S transition (Dalton, 1992; Cobrinik, 1996) . Surprisingly, recent in vivo footprinting experiments have not revealed any protein-DNA interaction at the expected location of the E2F responsive element in the human cdc2 promoter, suggesting that E2F could act via a dierent response element. It has been suggested that an E2F-4/DP-1/p130 complex inhibits cdc2 transcription by preventing the binding of the basal transcription machinery at the vicinity of the main transcription start site (Tommasi and Pfeifer, 1995) . This element, which has also been named CDE (for cell cycle-dependent element), is supposed to promote the coordinate repression of cdc2, cyclin A and cdc25C gene expression in G0 and in early G1 (Zwicker et al., 1995) . It also mediates inhibition of cdc2 transcription following TPA-induced differentiation of HL60 cells (Sugarman et al., 1995) . Cooperation between CDE and another element, named CHR (cell cycle gene homology region), is necessary to ensure cdc2 gene regulation by CDE (Zwicker et al., 1995; Tommasi and Pfeifer, 1995; Liu et al., 1996) . Although the factors that bind to the CHR responsive element remain to be characterized, some experimental data suggest that they would not belong to the E2F and DP families. Thus, in addition to E2F/DP complexes, other transcription factors also participate to the ®ne regulation of the cdc2 gene expression during the cell cycle (Liu et al., 1996) .
Indeed, a multiplicity of potential binding sites to transcription factors have been described in the human and the rat cdc2 promoter (Tommasi and Pfeifer, 1995; Shimizu et al., 1995a) . For instance, an activator responsive element located around position 7270 with respect to the main transcription start site of the rat cdc2 promoter, seems to participate in the activation of cdc2 transcription at the G1/S boundary (Shimizu et al., 1995a) . The factors that bind to these various responsive elements remain to be characterized. In contrast, a number of factors have already been described as regulators of cdc2 expression. Human cMyc, in cooperation with activated Ras can indirectly activate the cdc2 promoter (Born et al., 1994) . The product of c-myb transactivates cdc2 expression, this transactivation being possibly required at the G1/S transition (Ku et al., 1993) . Ets-2 is also a positive regulator of cdc2 expression (Wen et al., 1995) , but the precise biological signi®cation of this transactivation is presently unknown.
Numerous other transcription factors have been described that ensure cyclic expression of cell cycle regulatory proteins. Among them, the upstream stimulatory factors (USFs) have recently been implicated in the regulation of cyclin B1 gene transcription during the cell cycle. Interestingly this cyclin, like cdc2, is highly expressed in the G2 phase of the cell cycle and is the regulatory subunit of the cdc2/cyclin B kinase (Cogswell et al., 1995; Dalton, 1992) . USFs are ubiquitous transcription factors of the b/HLH/ZIP family, originally described as proteins able to bind the CACGTG sequence of the adenovirus major late promoter (MLP) (Sawadogo and Roeder, 1985; Sawadogo et al., 1988; Sirito et al., 1994) as homo or heterodimers (FerreÂ -D'AmareÂ et al., 1994; Gregor et al., 1990; Viollet et al., 1996) . The usf1 gene encodes a single 43 kD protein. The usf2 gene, due to alternative splicing, encodes two proteins: USF2a and USF2b of 44 kD and 38 kD respectively. USF2 isoforms dier in their N-terminal moieties, whereas they have identical b/HLH/ZIP domains (Viollet et al., 1996) . In addition to the cyclin B1 gene, they have been described as positive or negative regulators of numerous genes like cd2, a1 (I) collagen, a-subunit of F 0 F 1 -ATP synthase, ribosomal RNA (Breen and Jordan, 1997; Cogswell et al., 1995; Ghosh et al., 1997; Kenny et al., 1997; Outram and Owen, 1994; Rippe et al., 1997) via the USF responsive element CACGTG. Importance of USF2 during development is illustrated by the severe loss of body weight and major alteration of brain functions of USF 7/7 mice (Sirito et al., 1998; Vallet et al., 1997 Vallet et al., , 1998 .
We have recently reported that the quail cdc2 promoter contains an octamer sequence, currently named IG, that is necessary for cdc2 expression in avian cells (North et al., 1996) . Interestingly, sequences closely homologous to IG are found in the cdc2 promoters of both vertebrates and invertebrates, and also in the promoters of a number of major cell cycle regulatory genes. Here we show that USFs transcription factors transactivate the promoter of cdc2 via the IG motif. In vivo footprinting experiments and electromobility shift assay (EMSA) experiments, strongly suggest that these transcription factors participate in the control of cdc2 gene expression in vivo.
Results
In vivo genomic DMS footprinting of the promoter of cdc2 in the embryonic quail neural retina
We have previously reported that the IG motif found in the quail cdc2 promoter binds to at least three dierent complexes whose abundance is regulated during the development of quail neuroretina (North et al., 1996) . This observation suggested that some of these complexes could play a role in nerve cell dierentiation. To con®rm that the IG motif participates to the regulation of cdc2 gene expression during retinoblast dierentiation, a series of in vivo genomic footprinting have been carried out with the developing neural retina. In vivo DMS treatment and subsequent PCR ampli®cation show a strong protection from methylation mapping the IG motif in DNA from retinal cells, as compared to chromatin-free DNA (Figure 1 ). This indicates the presence of proteins bound to this motif in vivo that are possibly regulators of cdc2 gene expression in retinal cells. In addition to the IG motif, two regions are protected from DMS: one G residue at position 753, located upstream of the E2F binding site (see North et al., 1996) and two residues just below the IG motif. This region may correspond to the SP-1 binding site described in the human cdc2 promoter (see Tommasi and Pfeifer, 1995) . Proteins are probably constitutively bound to these regions since their occupation patterns do not vary during development of the neural retina.
In contrast, the guanine residue located at position 7112 in the IG motif, which is protected from DMS Figure 1 The IG motif is occupied by DNA-binding proteins in vivo. In vivo footprinting analysis of the non-coding strand of the region encompassing the IG motif (7135 to 753 relative to the transcription start site) in the developing retina (left panel, lanes 1 and 2) and in QNR cells (right panel, lanes 5 and 6). QNR cells were infected by the thermosensitive mutant strain RSV tsNY68 virus that triggers cell division at 378C but not at 418C. Analyses in retinas were performed at two developmental stages (embryonic days E4 and E14). Part of the sequence encompassing the IG motif is shown on the left: * protected residues, * protected G residues at E4 but not E14, * hyper-methylated residues, & G residues protected in embryonic neuroretina but not infected QNR in culture. The`in vitro' lanes (3 and 4) correspond to reactions carried out with protein-free genomic DNA methylation at embryonic day E4 (i.e. when retinal cells proliferate actively), is signi®cantly less protected at E14 (i.e. in dierentiated postmitotic cells). This shows that the occupancy of the region encompassing this particular residue vary during development, suggesting that the proteins bound to the IG motif may participate to the negative regulation of cdc2 gene expression during the switch from proliferation to quiescence in dierentiating quail neuroretina cells. This prompted us to analyse the IG protection in dividing or quiescent retinal cells (QNR) in culture.
Indeed, when QNR cells are infected by NYts68, a thermosensitive mutant strain of Rous sarcoma virus (RSV), they proliferate when cultured at the permissive temperature (378C) but remain quiescent at the nonpermissive temperature (418C). In such conditions, the footprinting experiments show that the IG motif is protected from DMS methylation at both temperatures and thus probably bound to proteins. The occupancy pattern observed with QNR cells in culture is very similar to the pattern obtained using developing neural retina. The same G residue (7112) whose occupancy pattern varies in developing retina, is much more protected in proliferating QNR cells in culture at 378C comparing to quiescent cells at 418C. However this residue is less protected in proliferating cells in culture than in growing embryonic cells at E4. These data suggest that dierent complexes may be bound to this region, depending on the proliferative state of QNR cells. Taken together, in vivo footprinting results support the idea that transcription factors binding to the IG motif may monitor cdc2 gene expression both in the developing retina and QNR cells in culture. These factors may therefore participate in the control of cell proliferation and/or cell dierentiation.
The b/HLH/Zip protein FIP-USF2 binds speci®cally to the IG motif
The nucleotide sequence of the IG motif (CACGGTGGC) has been ®rst described as an EBox (Ephrussi et al., 1985) , containing the consensus sequence of HLH factors (CANNTG). We then anticipated it could bind factors of the b/HLH/ZIP family. To characterize the IG binding proteins, we have performed a series of EMSA experiments using extracts from COS cells overexpressing dierent b/HLH/Zip proteins. The results depicted in Figure 2 show that COS cells overexpressing FIP (a truncated form of USF2a) exhibit a very high IG DNA binding activity which is aected by a three base mutation of the CAGGTGGC motif (m3) but neither by point mutations on the third (c3) nor on the eighth (c8) nucleotide of this motif (Figure 2 ). Moreover, this complex is supershifted in the presence of anti-FLAG antibodies recognizing the FLAG-tagged FIP protein (not shown). This further con®rms that the FIP protein can directly bind to the IG motif. In contrast, nuclear extracts from COS or QT6 cells accumulating the products of c-myc or mi have a low binding activity (not shown). These results suggest that the IG motif is a speci®c target for FIP (USF2) and that this interaction is not aected by a mutation of the third base of the consensus USF binding site CACGTG limiting this consensus to CANGTG.
Characterization of the USF dimers bound to the IG motif
As USF1 and USF2 isoforms can form homo-and heterodimers, six dierent dimers, which may have dierent anities for various E-boxes, can possibly be made. To characterize the USF dimers which bind to the IG motif found in the promoter of cdc2, human USF1, USF2a and USF2b were overexpressed in C33A cells either alone or in combination. The expression of the dierent USFs was controlled by Western blot analysis for each extract (data not shown). In addition, speci®c antibodies were used to directly identify USF isoforms by supershifting or inhibiting the complexes bound to the IG motif. Figure 3a shows that overexpression of USF1 alone does not result in the formation of a protein complex bound to IG, indicating that this protein has weak anity, if any, for this response element ( Figure 3a , lane 1). In contrast, in similar conditions, USF2a and USF2b were found to bind to IG. The observed bands (named U2a and U2b respectively) probably correspond to homodimers ( Figure 3a , lanes 2 and 3). Indeed, U2a but not U2b is inhibited by anti-USF2a antibody (`O' antibody, Figure 3c , lane 4), while both complexes are inhibited by`Z' antibody, raised against the common Zip domain of UFS2a and USF2b (Figure 3b , lanes 5 and 10). Anti-USF1 antibodies C20 and M have no eect on these complexes (Figure 3b, lanes 3, 4 and 8, 9) .
Interestingly, coexpression of USF2a and USF2b results in the formation of an additional complex of Figure 2 The FIP protein, containing the b/HLH/ZIP domains of USF2, binds speci®cally to the IG motif. Gel shift experiments using COS cell extracts. Extracts were prepared 48 h after transfection of the cells with 2 mg of the PSG5-FLAG-FIP vector, encoding the FLAG-tagged FIP protein. The expression of FIP was checked by Western blot analysis using a monoclonal antibody raised against the FLAG epitope (data not shown). Competition experiments using a 100-fold molar excess of wild type (wt) or mutated (m3, c3 or c8) cold competitor reveals that FIP/UFF2 interacts speci®cally with the IG motif (arrow). This complex is dissociated using either wt, c3 and c8 competitors (lanes 5, 3 and 4) but not m3 (lane 2) Figure 3 Characterization of USFs dimers which speci®cally bind to the IG motif. (a) Gel shift experiments were performed, using 2.5 mg of extracts from C33A cells overexpressing dierent combinations of proteins of the USFs family and 0.5 ng of the avian IG probe. Cells were transfected with either one single plasmid ± PCR3-USF1 (USF1, lane 1), PCR3-USF2a (USF2a, lane 2), PCR3-USF2b (USF2b, lane 3) ± or dierent combinations of USFs encoding plasmids PCR3-USF1 plus PCR3-USF2a (USF1/2a, lane 4), PCR3-USF1 plus PCR3-USF2b (USF1/2b, lane 5), PCR3-USF2a plus PCR3-USF2b (USF2a/2b, lane 6) ± as indicated. No speci®c complex was observed in extracts from cells expressing USF1 protein. Two dierent complexes (U2a and U2b) were observed in cell extracts overexpressing USF2a (lane 2) and USF2b (lane 3) respectively, as well as in cell extracts expressing both proteins (lane 6). In this case, an additional intermediate complex is observed (U2a/2b). Only the U2a complex is observed in cell expressing both USF1 and USF2a (U2a, lane 4). In contrast, in cells expressing both USF1 and USF2b, two complexes are observed: U2b and an additional complex U1/2b (lane 5). In each lane, a non-speci®c band is observed (*). (b) USF2a and USF2b isoforms can bind IG motif as homodimers. Supershift experiments were performed with extracts from cells overexpressing either USF2a (lanes 1 ± 5) or USF2b (lanes 6 ± 10). The antibodies used are indicated on top of each lane. The mobility of U2a and U2b complexes is only aected by Z antibody which speci®cally recognizes USF2a and USF2b isoforms (lanes 5 and 10), but not by M or C-20 antibodies which recognize USF1 protein (lanes 3, 4, 8 and 9) . PI labels the pre-immune antiserum used as a control (lanes 2 and 7), (±) labels a control without any antibody (lanes 1 and 6). (c) USF2a/USF2b and USF1/USF2b heterodimers can bind IG. Supershift experiment were performed with extracts from cells overexpressing either USF2a and USF2b (lanes 1 ± 5) or USF1 and USF2b (lanes 6 ± 10). The antibodies used are indicated on top of each lane. The mobility of U2a/2b complex is aected by O and Z antibodies recognizing respectively USF2a (O) or USFa and 2b (Z, lanes 4 and 5). No change is observed in the presence of the preimmune serum (PI, lane 2) or of the anti-USF1 antibody (M, lane 3). The mobility of U2b is not aected by the anti-USF2a intermediate electrophoretic mobility (U2a/b, see Figure 3a and c). This complex is supershifted by`Z' antibody and inhibited by`O' antibody,`M' antibody (anti-USF1) having no eect (Figure 3c , lanes 1 ± 5). These results suggest that it corresponds to USF2a/ USF2b heterodimer.
Coexpression of USF1 and USF2b leads to the formation of two complexes (Figure 3a, lane 5) . One of them corresponds to U2b, the other complex, migrating slightly faster than U2a/b, is supershifted both by anti-USF2 (`Z' antibody, Figure 3c , lane 10) and anti-USF1 (`M' antibody, Figure 3c , lane 8), but not by anti-USF2a (`O' antibody, Figure 3c , lane 9), indicating that this complex corresponds most probably to USF1/USF2b. In contrast, no USF1/USF2a heterodimer could be detected (Figure 3a and d) .
In conclusion, the EMSA analysis performed in C33A cells indicate that the IG motif of the cdc2 promoter is the target of a large combination of USF complexes, namely USF2a, USF2b homodimers and USF2a/USF2b, USF1/USF2b heterodimers.
To test whether these observations in the mammalian system were also relevant to avian neuroretinal cells, the antibodies directed against human USFs were used in supershift experiments with quail neural retina nuclear extracts prepared at various developmental stages. We ®rst analysed by Western blotting if these antibodies cross-reacted with avian USFs. Attempts to detect avian USF2a by Western blotting using`O' antibody were unsuccessful. Figure 4 shows that a single protein with the same mobility as human USF2b is revealed by`Z' antibody in retina extracts (panel A). Interestingly, this putative avian USF2b protein, is expressed at a constant level during the development of quail neural retina.`M' antibody also revealed the presence of a protein migrating at the same position as human USF1 (panel B). This latter protein, which was considered as avian USF1, displays a high level of expression between E5 and E8, and gradually disappears afterwards, being undetectable after E12; this suggests that USF1 expression, contrary to USF2b, is down-regulated in dierentiated retinal cells. On the basis of the Western blot results, we used`M' (anti-USF1) and`Z' (anti-USF2) antibodies to supershift IG-binding complexes in EMSA experiments carried out with quail retina extracts.
As shown in Figure 5a and b four complexes (a ± d) contribute to the whole IG DNA binding activity in retina nuclear extracts. Qualitative and quantitative changes of IG DNA binding activity can be observed from E5 ± 14 developmental stages. Quanti®cation analysis (Figure 5c ) shows that the whole IG DNA binding activity is signi®cantly lower in the mature retina (E14) as compared to the undierentiated retina (E5 ± 7), a peak of activity being observed at E7. Interestingly, the relative amount of the dierent complexes which is not signi®cantly modi®ed between E5 and E7, changes dramatically at E14. At this stage, complex b becomes predominant, representing 65% of the total IG DNA binding activity.
These results indicate that abundance and/or composition of the complexes bound to the IG sequence vary during development, which is in good agreement with the in vivo footprinting data and suggest that they may be involved in some of the cell dierentiation events occurring in the development neural retina.
In order to evaluate the contribution of USF complexes to the IG DNA binding activity in the developing retina, a series of supershift experiments have been carried out. Figure 6 shows that both anti-USF1 and anti-USF2 antibodies (lanes 2 and 3), but neither pre-immune serum nor an anti-Rb antibody (lanes 4 and 5), inhibit formation of complex b, suggesting that complex b corresponds to USF1/ USF2 heterodimer at E7. Interestingly, in the mature retina (E14) band b is suppressed following incubation of the extracts with anti-USF2, while anti-USF1 has no eect ( Figure 6, lanes 7 and 8) . This strongly suggests that composition of complex b varies during development, corresponding to USF2/USF1 heterodimer in the dierentiating retina (E7) and to USF2 homodimer at E14.
Formation of complex a is inhibited by antibodies Z and M but also to some extent by the pre-immune serum, indicating that this eect may be non-speci®c.
The other bands (c and d, see Figure 6 ) were not supershifted by the anti-USF antibodies used in this study, suggesting that they probably did not contain USF1 or USF2b. The composition of these potentially activating complexes remains to be determined. 
Transactivation of cdc2 by USFs
Because EMSA experiments are consistent with the occurrence of dierent speci®c USF complexes on the IG motif of the cdc2 promoter, we have set out to study their ability to modulate its transcriptional activity of the cdc2 promoter. To assess this point, a series of cotransfection experiments have been carried out using the cdc2 proximal promoter cloned upstream of a CAT reporter gene (cdc2-CAT construct, see North et al., 1996) . As depicted in Figure 7a , the three USFs act as transactivators. A 3-base mutation in the IG motif severely depresses this transactivating eect, indicating that it is mediated by the IG motif thus behaving as an USF-responsive element. Interestingly, USF2a can still partly transactivate the mutated cdc2 promoter, suggesting that it may directly or indirectly activate the promoter via other regulatory elements. Compared to the two other factors, USF1 appears to be a poor transactivator. This may be due to the weak anity of USF1 for the IG motif and/or to the large amount of endogenous USF1 in Hela cells as revealed by Western blot analysis (Figure 7b, lanes 4 and 5) . This could also explain why the coexpression of USF1 . EMSA experiments were performed as described in Materials and methods, using 7.5 mg of nuclear extracts from embryonic neuroretinal cells isolated at E5, E7 and E14 (as indicated on the top of each lane). Four complexes can be observed, noted a, b, c and d. The abundance of each complex varies depending on the day of development. Complex a is observed from E5 to E14 but becomes hardly detectable at E14. Complexes c and d can be seen at each stage but are more abundant at E7. Complex b is observed at each stage and predominant at E14. The whole DNA binding activity on the IG probe increases from E5 ± 7 and then decreases again at E14. (b) Four complexes bind speci®cally to the IG probe. Autoradiograms of competition experiments, using a 50-fold molar excess of wild type (wt), mutated (m3) or unrelated (ur) cold competitor, reveals that the four complexes (a, b, c, d) interact speci®cally with the IG motif. These complexes are dissociated using the wild type (wt) competitor but neither by the mutated (m3) nor by an unrelated (ur) cold competitor. (c) Quanti®cation of the DNA binding activity on the IG probe. The relative amount of each complex in the EMSA experiment shown in a has been quanti®ed using a PhosphorImager. Each band (complexes a ± d, see a) has been quanti®ed. Abundance of each complex is shown by vertical bars. Intensity of the radioactivity is indicated (vertical axis, 610 3 c.p.m. band). This quanti®cation con®rms that the complex a (white bars) is observed from E5 ± 14, its intensity strongly decreasing (divided by 8.8) between E7 and E14. Complex c (hatched bars) and d (black bars) are predominantly observed at E7, respectively representing 31% and 24% of the IG DNA binding activity at E7. Complex b (grey bars) is observed at each stage, representing 28% of the total DNA binding activity at E5 and E7 and 64% at E14 with either USF2a or USF2b does not enhance their transactivating eect on the quail cdc2 promoter (data not shown). Moreover, due to the high level of endogenous USF1 in HeLa cells, activation of cdc2 transcription in USF2-transfected cells could be due to either USF2 homodimer or USF1/USF2 heterodimer or both. To discriminate between these possibilities, transfection experiments have been performed in wild type and USF1 7/7 mouse embryo ®broblasts (MEF). In USF1 7/7 MEF, transfection of pCR3-USF2b (500 ± 1000 ng) results in an inhibition of cdc2 transcription (Figure 7c, lanes 8 and 9) , which could be due to USF2b homodimer. Interestingly, this inhibitory eect can be suppressed by cotransfecting pCR3-USF1 plasmid (compare lanes 9 and 11, Figure  7c) .
In wt MEF, transfection of pCR3-USF2b (up to 500 ng) results, by contrast, in a slight activation of cdc2 transcription, possibly due to USF1/USF2b dimer (Figure 7c, lanes 3 and 4) . At higher doses of USF2b transfected plasmid (100 ng, Figure 7c , lane 5), this activation is no longer observed, which could be due to titration of endogenous USF1 and subsequent accumulation of USF2b dimer (see Figure 7d , lane 4). Taken together, these results raise the possibility that USF2b homodimer may be a transrepressor while USF1/USF2b heterodimer could activate cdc2 transcription. In USF 7/7 MEF transfected with low doses of pCR3-USF2b (50 ng), the amount of USF2a and USF2b are similar as shown by Western blot ( Figure  7d , lane 6), suggesting that the slight activation of cdc2 transcription observed in these conditions may be due to USF2a/USF2b heterodimer (Figure 7c, lane 8) .
Discussion
A major step in the development of the neural retina, as well as in most organs, involves the entry of dierentiating cells into quiescence. In the case of retinoblasts, this is a point of no return since dierentiated neurons of the central nervous system (CNS) are unable to re-enter the cell division cycle. Speci®c mechanisms may thus take place in neurons to ensure this de®nitive arrest of cell proliferation. A critical event in the developing avian retina is the down-regulation of cdc2 gene expression (Espanel et al., 1997; North et al., 1996) . A precise understanding of the molecular mechanisms involved in this downregulation may shed some light on the links between the regulation of cell division and cell dierentiation in the nervous system of higher eukaryotes. In this report, we used an in vivo footprinting strategy to characterize the regions of the cdc2 promoter which are occupied by transcription factors during the quail neural retina development. We have previously reported that cdc2 gene expression was under the control of both E2F-1 and other transactivating factors which have anity for a particular E-box (currrently named IG) located at position 7115, relative to the main transcription start site (North et al., 1996) .
The results presented in the ®rst part of this report, extend these data and clearly show that this element is occupied by proteins in cultivated neuroretina cells and in vivo in the cells of the developing organ. It has been reported that the IG-like motif (CAGTTGGC) of the human cdc2 promoter seems to be occupied by proteins in vivo in ®broblast cells (Tommasi and Pfeifer, 1995) . Although these authors suggest that this occupation pattern may be due to proteins bound to the neighbouring SP-1 site, our observations made on the avian promoter, lead us to suggest that this IG-like motif may also be occupied by proteins having a speci®c anity for this particular E-box. However the role of this IG-like element in the regulation of cdc2 gene expression throughout the cell cycle is unclear since the occupation pattern is unchanged in cells synchronized in dierent phases of the cell cycle (Tommasi and Pfeifer, 1995) . By contrast, in the quail cdc2 promoter, the occupancy pattern of the IG motif varies during the development of the neural retina. This variation correlates with the level of cdc2 expression and the proliferative state of retinal cells (Espanel et al., 1997; North et al., 1996) . These data support the hypothesis that the IG motif, which is correspond to E7 nuclear extracts, lanes 6 ± 8 correspond to E14 nuclear extracts. Lanes 2 and 3 show that the formation of complex a at E7 is inhibited by addition of antibodies recognizing either USF1 (M antibody) or both USF2 isoforms (Z antibody). Complex a is also partly inhibited by pre-immune serum (S, lane 4) and, to a lesser extent, by an unrelated antibody (Rb, lane 5), raising a doubt concerning the speci®city of the eect observed with M and Z antibodies. By contrast, the formation of complex b is neither aected by the pre-immune serum (4), nor by the Rb antibody (5), but only by antibodies recognizing either USF1 (M antibody, lane 3), or both USF2 isoforms (Z antibody, lane 2). These results indicate that complex b observed at E7 contains USF2 and USF1 proteins. Complex c and d are not aected by any of these antibodies. Lanes 7 and 8 show that the complex b of E14 extracts is only destabilized by addition of Z antibody, recognizing USF2 (lane 7), but not the M antibody, recognizing USF1 protein (lane 8). These results indicate that complex b corresponds USF1/USF2 heterodimers at E7 and to USF2 homodimer at E14 necessary for the basal expression of cdc2 in cycling cells (North et al., 1996) , may participate to the regulation of cdc2 transcription during cell differentiation.
The second part of this report aimed at identifying the transcription factors which regulate cdc2 gene expression via the IG sequence. We show for the ®rst time that a combination of dierent USFs may participate to the transcriptional control of cdc2 gene expression, via the IG motif. Indeed, over-expression of USFs in Hela cells induced an activation of both quail and human (not shown) cdc2 promoter. Moreover, supershift experiments suggest that dierent USF homo-and hetero-dimers can bind to the IG sequence which diers from the previously described USFresponsive element by a point mutation at the third position in the CACGTG consensus sequence (Viollet et al., 1996) . Interestingly, USF1 homodimer is unable to bind to the IG motif, suggesting that the third base of the consensus may therefore discriminate between USF1 and USF2-responsive elements.
Both Northern blot (data not shown) and Western blot analysis, revealed the presence of mRNA and proteins that correspond to USF1 and USF2b in developing neuroretinal cells. Interestingly, USF1 protein level decreases around E8-9, i.e. when cdc2 is down-regulated in those cells (North et al., 1996) and when the in vivo footprint of the IG motif of cdc2 promoter changes. By contrast, USF2b expression level remains constant. These results suggest that USF1/ USF2b heterodimers may well be responsible, at least in part, for the high level of cdc2 expression in retinoblasts. After E9, the maintenance of a high level of USF2b expression in retinal cells induces the formation of USF2b homodimers. Indeed, results of the EMSA experiments show that USF1/USF2b heterodimer bind IG at E7, and is later on replaced by USF2 homodimer which is the predominant complex bound to IG at E14. Interestingly, USF2 homodimer has been described as inhibitor of ribosomal RNA gene expression (Ghosh et al., 1997) . It may therefore be speculated that USF2 homodimer could similarly actively repress cdc2 gene expression in the mature retina. This hypothesis is supported by our transfection experiments performed in MEF, suggesting that USF2b homodimer could repress cdc2 gene expression in USF1 7/7 cells and, in contrast, could activate cdc2 transcription in wild-type (wt) cells through USF1/USF2b heterodimer. cdc2 gene expression could therefore be monitored, at least in part, by the relative amounts of USF2 homodimer and USF1/ USF2 heterodimer in vertebrate cells.
Taken together these data suggest that the in vivo footprinting pattern observed at E4 is due to USF1/ USF2 heterodimers and to a combination of still uncharacterized transcriptional regulators. The variations in the occupancy pattern between E4 and E14 may therefore result from both the disappearance of these dierent complexes and the accumulation of USF2 homodimer which may act as a transcriptional repressor in quiescent neurons.
Our results suggest that USFs could control cell cycle progression by regulating transcription of cdc2 and other cell cycle-regulating genes. This idea is supported by the antiproliferative properties of USFs in transformed REFs (Luo and Sawadogo, 1996) and the presence of IG-like elements in a number of genes involved in cell cycle control as shown in Figure 8 . Moreover, direct involvement of USF1 in the regulation of cyclin B1 gene expression has been demonstrated (Cogswell et al., 1995) . These authors showed that USF1 activates the transcription of a reporter plasmid containing both the USF binding site (position 7190/7185, relative to the transcription start site) and the IG motif (position 7236/7227). This activating eect was lost when a shorter construct that does not contain the USF binding site was used. This led to the conclusion that USF1 activates cyclin B1 expression via this particular motif. However, this last construct also lacks the IG motif. Therefore, one cannot exclude that the activating eect of USF on cyclin B1 promoter also requires the IG motif. Interestingly, an IG motif is also present in the promoter of cdk2 whose expression is downregulated in the developing retina together with cdc2 (Espanel et al., 1997; Kastner et al., 1998 ). The IG motif could then be one of the elements of the regulating pathway that ensures a coordinate expression of cdc2, cdk2 and cyclin B1 during the cell cycle and the synchronous down-regulation of these proteins observed in the developing neuroretina (Espanel et al., 1997) .
In conclusion, we have identi®ed a new USF2 binding site involved in the regulation of cdc2 gene expression. We have shown that USFs can modulate cdc2 promoter activity via this motif. Taken together, a b USFs regulating cdc2 expression S North et al these results argue for a role of USFs in the regulation of transcription in dierentiating nerve cells.
Materials and methods

Cell culture and protein overexpression
Human C33A carcinoma cells, HeLa cells, and simian COS cells were cultivated in DMEM (GIBCO BRL) supplemented with 10% SVF (BioWhittaker) or 5% SVF during transfection. QNR cells, isolated from fresh embryonic retina at E7 were infected by a thermosensitive strain of Rous Sarcoma Virus (RSV TsNY68) and grown on CEF medium as already described (Gillet et al., 1993) . MEF cells were obtained from 12.5 day-old wt or USF1 7/7 mouse embryos (Vallet et al., 1998) . COS cells overexpressing the FLAG-tagged FIP protein were obtained by transfecting 10 6 cells with 2 mg of PSG5-FIP using calcium phosphate procedure (North et al., 1996) . Cells were lysed 36 h after transfection. FIP expression was analysed by Western blot analysis using a monoclonal antibody raised against the FLAG epitope (M2, Kodak). C33A cells overexpressing USFs were obtained by transfecting 10 6 cells either with one single plasmid ± PCR3-USF2a (2 mg), PCR3-USF2b (2 mg), PCR3-USF1 (4 mg) ± or with combinations of plasmids PCR3-USFa (2 mg) plus PCR3-c d Figure 7 USFs transactivate the cdc2 gene promoter. (a) Transcriptional activation of the cdc2 promoter by USFs. CAT assays were performed as described in Materials and methods (a, c), USF expression levels were examined by Western blot analysis for each point of transfection (b, d) . Four mg of cdc2q-CAT (black columns) or cdc2q-Igm3-CAT (shaded) reporter plasmids were transfected in human HeLa cells, either with PCR3 (600 ng) or plasmids encoding respectively USF2a (100 ng), USF2b (50 ng), USF1 (1 mg) as indicated. PCR3 was added to PCR3-USF2a and PCR3-USF2b to ensure the same amount of PCR3 plasmid promoter sequence. USF2a, USF2b and USF1 signi®cantly enhance the activity of the wild type promoter, but neither USF2b nor USF1 can transactivate a cdc2 promoter which is mutated in the IG motif. (b) Control of the expression of the transfected USFs encoding plasmid. Protein expression levels were examined by Western blot analysis for each point of transfection using M antibody recognizing USF1 and G antibody recognizing USF2a and USF2b. Lanes 1 and 4 show the levels of endogenous USF1 and USF2 proteins in HeLa cells transfected with PCR3 plasmid (600 ng). No expression of endogenous USF2 is detectable (lane 1); a non speci®c band observed using G antibody (*). USF1 protein level is already detectable in HeLa cells transfected with PCR3 vector (lane 4). Lanes 2, 3 and 5, correspond to HeLa cells transfected with respectively PCR3-USF2a (100 ng), PCR3-USF2b (50 ng) and PCR3-USF1 plasmids (1 mg). The three USF proteins are expressed in transfected HeLa cells used for CAT assay experiments. (c) CAT assays in wt or USF1 k.o. MEF showing the opposite eects of USF2b/USF2b and USF1/USF2b dimers on cdc2 transcription. Four mg of cdc2q-CAT reporter plasmids were transfected in wt (left panel) or USF1 7/7 (right panel) MEF, either alone (lanes 1 and 6) or with PCR3 (600 ng, lanes 2 and 7) or increasing amounts of pCR3-USF2b (50 ng, lanes 3 and 8; 500 ng, lanes 4 and 9; 1 mg, lanes 5 and 10) or pCR3-USF2b together with USF1 (500 ng and 50 ng respectively, lane 11). USF2b overexpression activates cdc2 transcription in wt cells (lanes 3 ± 5). In contrast, transcription is repressed by USF2b in USF1 5) . Lanes 2 ± 4 and 6 ± 8 correspond to cells transfected with pCR3-USF2b (50 ng, 500 ng and 1 mg). Increasing amount of USF2b is detected in both cell types USF1 (4 mg), PCR3-USF2b (2 mg) plus PCR3-USF1 (4 mg), PCR3-USF2a (2 mg) plus PCR3-USF2b (2 mg). In all these experiments, expression vector concentration was maintained at the same level by addition of corresponding amounts of empty vector (PCR3). Expression of USFs was examined by Western blot analysis using polyclonal antibodies raised against USF1 (C-20, M), USF2a (O) or both USF2a and USF2b (Z, G). C-20 is from Santa Cruz, antibodies M, O, Z and G have been described (Viollet et al., 1996) .
PSG5-FIP was obtained by cloning a BglII ± BglII fragment of FIP mRNA in a modi®ed PSG5-FLAG vector which contains the FLAG epitope (Kodak). This plasmid encodes the fusion protein FLAG-FIP, lacking the ten ®rst amino acids of FIP but containing the whole HLH and ZIP domains. PCR3-USF2a, PCR3-USF2b, PCR3-USF1 encoding human USFs have been described elsewhere (Viollet et al., 1996) .
CAT assays
The reporter plasmid cdc2q-CAT, containing quail cdc2 promoter region has been described (North et al., 1996) . cdc2 Igm3-CAT was obtained by mutagenesis, using the Transformer kit (Clontech). Three bases of the IG motif were changed from 5'-CAGGTGGC to CAAACGGC.
CAT assays were performed as previously described (North et al., 1996) . 10 6 cells were transfected, using calcium phosphate procedure, with 4 mg of the cdc2 reporter plasmids in combination with 2 mg of control b-actin-LacZ and dierent amounts of USF-expressing plasmids (as indicated in legends to ®gures), with varying amounts of PCR3 in order to use the same amount of SV40 promoter. Cells were harvested 36 h after transfection, lysed with 1 ml of lysis buer (Boehringer). CAT-ELISA were performed using 200 ml of cell lysate. CAT activity was calibrated against bgalactosidase activity, (Herbomel et al., 1984) , or total protein amount (Figure 7c ). All experiments have been performed at least in triplicates. The expression of the USFs encoded by the transfected PCR3 plasmids was controlled by Western blot.
Gel retardation experiments (EMSA)
C33A or COS extracts were prepared from at least 4610 7 cells. Cells were washed twice in ice-cold PBS, pellets were then resuspended in 1.5 volume of lysis buer (20 mM HEPES pH 7.9, 0.4 M NaCl, 25% glycerol, 1 mM EDTA, 2.5 mM DTT, 1 mM PMSF). After a 20 min incubation on ice, extracts were frozen at 7808C, thawed on ice and then vigorously vortexed. Supernatants were recovered by centrifugation for 2 min at 48C (18 000 g).
Aliquots were then frozen in liquid nitrogen and stored at 7808C.
Fresh neuroretina nuclear extracts were prepared from quail embryos as previously described (North et al., 1996) with the following modi®cation: a cocktail of proteases inhibitors (Complete, Boehringer), ortho-vanadate (10 mM) and b-glycerophosphate (10 mM) were added to lysis buer. EMSA experiments were performed as previously described (North et al., 1996) using 2.5 mg of proteins (from C33A and COS cells) incubated with 500 or 1000 ng of sonicated salmon sperm DNA, 0.5 ng of the radiolabeled short IG probe and incubated in EMSA buer for 30 min at 48C (North et al., 1996) . For fresh embryonic retinal extracts, 7.5 mg of nuclear extracts were incubated with 2 ng of thè long' radiolabeled IG probe and 500 ng of sonicated salmon sperm in a modi®ed binding buer (Tris 20 mM pH 7.9, KCl 50 mM, MgCl 2 4 mM, EDTA 0.3 mM, ZnCl 2 3 mM, glycerol 10%).
IG probes consisted in double stranded oligonucleotides radiolabelled using g 33 P-ATP (Amersham). Competition experiments were carried out using various amounts of wild type (wt), mutated (m3, c3 and c8) or unrelated (ur) nonradioactive competitor oligonucleotides. Quail IG probes are derived from quail cdc2 promoter sequence, the`short' one encompassing 30 nucleotides of the promoter and the`long' one encompassing the ten following 3' nucleotides, covering the entire footprint of this region. IG short probe 5'-GATCCCACACCAGCAGGTGGCGCTGTGGTGCGG-IG long probe 5'-TCCCACACCAGCAGGTGGCGCTGTG-GTGCGGGACGTGCCGCTC-(IG motif is underlined). Mutated short competitor (m3) contains three mutations (bold) in the IG motif, corresponding to mutations performed in the cdc2qIgm3-CAT reporter plasmid 5'-GATCCCACACCAGCAAACGGCGCTGTGGTGCGG-. C3 and c8 are mutated on the third or the eighth base of the IG motif, respectively: c3; 5'-ACACCAGCATGTGG-CGCTGTGG-, c8; 5'-ACACCAGCAGGTGGTGCTGT-GG-. The unrelated oligonucleotide, (ur) is the following: 5' -AACTCCTCTAG CTGG GACCAACCAGCCCCGAGC-CGCT. Quanti®cation of IG DNA binding activity was performed using a Storm 840 PhosphorImager (Molecular Dynamics) and ImageQuant software.
Supershift experiments: the antibody of interest was preincubated with nuclear extracts for 40 min at 48C before probe addition. Samples were then further incubated for 30 min at 48C. 3 mg of anti-FLAG (M2, Kodak), 1 mg of anti-USF1 (C-20, Santa Cruz), 1 mg of anti-Rb (14001A, Pharmingen) or 1.5 ml of rabbit polyclonal (M, O, or Z antibodies) or pre-immune serum were used (Viollet et al., 1996) .
Western blot
Freshly dissected embryonic neuroretina from E4 ± 14 or transfected cells corresponding to each point of CAT assay experiment, were lysed in RIPA buer (50 mM Tris pH 8, 150 mM NaCl, 1% NP40, 0.5% DOC, 0.1% SDS, PMSF 1 mM, DTT 2.5 mM) containing protease inhibitors (Leupeptin 0.5 mg/ml, Aprotinin 0.1 mg/ml). SDS ± PAGE was performed using 40 mg (neuroretina) or 5 mg (HeLa, MEF) of total protein extract per sample, followed by transfer to nitrocellulose ®lters and sequential incubation with a primary antibody, Z, G or M (dilution 1/500) and a peroxydase-linked antibody to rabbit immunoglobulins (PO448 DAKO). Immunoblots were developed according to the ECL procedure (Amersham). For HeLa cells extracts, USF1 and USF2 proteins were revealed using respectively M and G primary antibodies. In the case of retina cell extracts, the nitrocellulose membrane was ®rst probed with anti-USF2a/b Z antibody and then reprobed using M antibody. 
Genomic footprinting
Freshly dissected embryonic neuroretina were treated with 0.2% dimethyl sulfate (DMS; Aldrich) in culture medium or PBS buered with 20 mM HEPES (pH 7.3) for 5 min at room temperature. DMS was then removed and samples were washed three times in PBS containing 2% bmercaptoethanol and incubated in lysis buer (50 mM Trish pH 8, 20 mM ETDA, 1% SDS, 2% b-mercaptoethanol) for 5 ± 10 min at room temperature. After three phenol/chloroform extractions at 48C, DNA was precipitated with 2M ammonium acetate in 2.5 volumes of ethanol. DNA pellets were resuspended in sterile water and DNA was subsequently cleaved by 10% piperidine at 958C for 30 min. After cleavage, piperidine was removed by three adsorptions on cold eppendorf tube, two ethanol precipitations and one lyophilization. Two mg of cleaved DNA were ampli®ed by ligation-mediated PCR (LMPCR; (Espinas et al., 1994) ) in the presence of 10% DMSO. Ampli®ed fragments were separated on a 6% polyacrylamide-7M urea sequencing gel in 16TBE (Tris-borate-EDTA). The third primer from the appropriate quail cdc2 primer sets was labeled with g 32 P-ATP using the T4 polynucleotide kinase (Promega). In vitro control was performed with chromatin-free DNA puri®ed from QNR cells in culture. This DNA was methylated at 208C for 4 min, in DMS buer (50 mM sodium cacodylate pH 8, 1 mM EDTA) containing 0.5% DMS. The reaction was stopped by 0.3 M sodium acetate and 20% b-mercaptoethanol. The following primers set was used to analyse quail cdc2 promoter (non coding strand): AScdc2A: 5'-GGC-CGCTCAGTGCTCAGCCG-3'; AScdc2B: 5'-CCGGGGC-GGGCGACGACCATTCG-3'; AScdc2C: 5'-CGACCAT-TCGAACCCGCCGCTC-3'.
